Leading biogerontologist João Pedro de Magalhães says that longevity pharmacology has come of age, and discusses rapamycin and Calico.
Leading biogerontologist João Pedro de Magalhães says that longevity pharmacology has come of age, and discusses rapamycin and Calico.
Comments are closed.